| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Stefanadis C | |
| Toutouzas P | |||
| Tousoulis D | |||
| Tentolouris C | |||
| Goumas G | |||
| P2860 | cites work | Role of endothelium-derived nitric oxide in the regulation of blood pressure | Q28242958 |
| Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris | Q28246683 | ||
| Vascular endothelial cells synthesize nitric oxide from L-arginine | Q28291036 | ||
| Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure | Q28297273 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney | Q28359320 | ||
| The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
| Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide | Q29619956 | ||
| NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide | Q33575382 | ||
| An L-arginine/nitric oxide pathway present in human platelets regulates aggregation | Q33674149 | ||
| Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase | Q33865641 | ||
| The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine | Q33882001 | ||
| Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension | Q34170380 | ||
| L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats | Q34208507 | ||
| Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. | Q34223377 | ||
| Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans | Q34256239 | ||
| L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance | Q34345457 | ||
| Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells | Q34573717 | ||
| Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure | Q35371877 | ||
| Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects. | Q35532246 | ||
| Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. | Q54162413 | ||
| Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. | Q54189353 | ||
| L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. | Q54195872 | ||
| Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. | Q54198187 | ||
| Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. | Q54225996 | ||
| Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. | Q54240963 | ||
| Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. | Q54243794 | ||
| Effects of L-arginine on forearm vessels and responses to acetylcholine | Q54261202 | ||
| L-Arginine as an Antihypertensive Agent | Q54282687 | ||
| Dilator actions of arginine in human peripheral vasculature | Q54286330 | ||
| L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. | Q54310603 | ||
| Role of endothelium-derived nitric oxide in the regulation of tonus in large-bore arterial resistance vessels, arterioles and veins in cat skeletal muscle. | Q54313178 | ||
| Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. | Q54322623 | ||
| NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? | Q54355366 | ||
| Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. | Q55066434 | ||
| Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication | Q57791545 | ||
| Dietary l-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms | Q60723135 | ||
| Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits | Q60723154 | ||
| Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production | Q60723170 | ||
| A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox” | Q61940316 | ||
| Chronic dietary supplementation with ?-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo | Q63184879 | ||
| Dietary l-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits | Q63184881 | ||
| Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease | Q63184884 | ||
| Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits | Q63184888 | ||
| Effects of oral administration of L-arginine on renal function in patients with heart failure | Q73491823 | ||
| Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women | Q73535751 | ||
| Serum cholesterol level, cigarette smoking, and vasomotor responses to L-arginine in narrowed epicardial coronary arteries | Q73574912 | ||
| Coronary stenosis dilatation induced by L-arginine | Q73620129 | ||
| Oral L-arginine in patients with coronary artery disease on medical management | Q73762604 | ||
| Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation | Q73832085 | ||
| Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors | Q74302884 | ||
| Endothelial function of internal mammary artery in patients with coronary artery disease and in cardiac transplant recipients | Q74322955 | ||
| Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease | Q74426928 | ||
| Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide | Q74589838 | ||
| Regression of atherosclerosis: role of nitric oxide and apoptosis | Q74590428 | ||
| Continuous perivascular L-arginine delivery increases total vessel area and reduces neointimal thickening after experimental balloon dilatation | Q74598510 | ||
| Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans | Q74645901 | ||
| Arginine consumption in coronary disease | Q74747771 | ||
| Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure | Q74768966 | ||
| Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans | Q74779487 | ||
| L-arginine: effect on reperfusion injury after heart transplantation | Q74797647 | ||
| Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X | Q77312958 | ||
| A large blood pressure-raising effect of nitric oxide synthase inhibition in humans | Q77330674 | ||
| Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure | Q77367253 | ||
| Nitric oxide synthesis in atherosclerosis | Q77575511 | ||
| Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris | Q77769400 | ||
| Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries | Q77781924 | ||
| L-arginine reduces right heart hypertrophy in hypoxia-induced pulmonary hypertension | Q77911595 | ||
| Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma | Q78213020 | ||
| L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans | Q35606367 | ||
| Hypercholesterolemia increases endothelial superoxide anion production | Q35610616 | ||
| Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit | Q35822869 | ||
| Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. | Q37354435 | ||
| The vascular effects of L-Arginine in humans. The role of endogenous insulin | Q37363072 | ||
| Nitric oxide: an endogenous modulator of leukocyte adhesion | Q37519420 | ||
| Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. | Q39397341 | ||
| L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits | Q40340324 | ||
| Nitric oxide: mediator, murderer, and medicine | Q40622626 | ||
| Endothelial function in congestive heart failure | Q40841227 | ||
| Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers | Q41027238 | ||
| Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine | Q41469396 | ||
| Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides | Q41640232 | ||
| Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells | Q41660144 | ||
| Improvement of cardiac performance by intravenous infusion of l-arginine in patients with moderate congestive heart failure | Q41673266 | ||
| Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke | Q41679296 | ||
| Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism | Q41724429 | ||
| Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries | Q41853016 | ||
| Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit | Q42133850 | ||
| Amino acids dilate resistance blood vessels of the perfused rat mesentery | Q42190892 | ||
| Nitric oxide modulation of neutrophil-endothelium interaction: difference between arterial and venous coronary bypass grafts. | Q42453044 | ||
| LDLs impair vasomotor function of the coronary microcirculation: role of superoxide anions | Q42460475 | ||
| l-Arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation | Q42560740 | ||
| L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells | Q42563024 | ||
| Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity | Q42713508 | ||
| L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. | Q45089990 | ||
| Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis | Q45207667 | ||
| L-arginine evokes both endothelium-dependent and -independent relaxations in L-arginine-depleted aortas of the rat. | Q45226928 | ||
| Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. | Q46024028 | ||
| Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. | Q46037040 | ||
| Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit | Q46086523 | ||
| Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits | Q46087047 | ||
| Effects of L-arginine and N omega-nitro-L-arginine methyl ester on cardiac perfusion and function after 1-day cold preservation of isolated hearts | Q46154663 | ||
| L-Arginine normalizes coronary vasomotion in long-term smokers | Q46487533 | ||
| Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure | Q46861533 | ||
| NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? | Q48519024 | ||
| Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. | Q49065954 | ||
| Myocardial contractile effects of L-arginine in the human allograft. | Q50621731 | ||
| Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. | Q50885317 | ||
| L-arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation. | Q50887714 | ||
| Role of the endothelium and arginine peptides on the vaso-motor response of porcine internal mammary artery. | Q50892077 | ||
| Vasodilatory properties of mono-L-arginine-containing compounds. | Q50895195 | ||
| Endothelium dependent vascular relaxation by arginine containing polypeptides. | Q50906225 | ||
| Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C. | Q50969660 | ||
| Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit. Response according to treatment duration, anatomic site, and sex. | Q51016545 | ||
| Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. | Q51576241 | ||
| Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. | Q51585513 | ||
| L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery. | Q54082143 | ||
| Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. | Q54121894 | ||
| Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension. | Q54130792 | ||
| Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. | Q54130794 | ||
| Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. | Q54131232 | ||
| Life-threatening hyperkalemia induced by arginine | Q67414278 | ||
| The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat | Q67490908 | ||
| L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans | Q67504169 | ||
| Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine | Q68059399 | ||
| L-arginine-induced hypotension | Q68095216 | ||
| L-arginine-induced hypotension | Q68293600 | ||
| Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine | Q68326802 | ||
| Vascular activity of polycations and basic amino acids: L-arginine does not specifically elicit endothelium-dependent relaxation | Q69051513 | ||
| Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo | Q69439357 | ||
| L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo | Q69734585 | ||
| Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium | Q69908131 | ||
| Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide | Q70168117 | ||
| Crucial role of endothelium in the vasodilator response to increased flow in vivo | Q70275801 | ||
| Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells | Q70495492 | ||
| L-arginine inhibits balloon catheter-induced intimal hyperplasia | Q70742086 | ||
| L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study | Q71047041 | ||
| L-Arginine does not restore dilatation of the basilar artery during diabetes mellitus | Q71059079 | ||
| Expression of inducible nitric oxide synthase in human heart failure | Q71129305 | ||
| Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms | Q71170633 | ||
| Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesterolemia | Q71436526 | ||
| Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients | Q71571212 | ||
| Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? | Q71731726 | ||
| Basal nitric oxide production by diseased coronary arteries | Q71776455 | ||
| Pressor, renal and endocrine effects of l-arginine in essential hypertensives | Q71814969 | ||
| Aging-associated endothelial dysfunction in humans is reversed by L-arginine | Q71879928 | ||
| Discordant Effects of Dietary L-Arginine on Vascular Structure and Reactivity in Hypercholesterolemic Rabbits | Q71944729 | ||
| Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus | Q72133348 | ||
| Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients | Q72238549 | ||
| Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis | Q72248410 | ||
| Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium | Q72285314 | ||
| Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology | Q72344139 | ||
| Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats | Q72414928 | ||
| Aging and endothelial function in normotensive subjects and patients with essential hypertension | Q72642229 | ||
| Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion | Q72677207 | ||
| Sex differences in endothelial function in normal and hypercholesterolaemic subjects | Q72687147 | ||
| L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits | Q72696242 | ||
| Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans | Q72726505 | ||
| Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans | Q72800911 | ||
| Role of nitric oxide in exercise-induced vasodilation of the forearm | Q72893572 | ||
| Arginine: a new therapy for atherosclerosis? | Q73012571 | ||
| L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice | Q73012628 | ||
| Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis | Q73114809 | ||
| Inhibition of nitric oxide synthesis in human epicardial coronary arteries and stenoses in relation to serum lipid level | Q73176757 | ||
| Effects of inhibition of nitric oxide synthesis in patients with coronary artery disease and stable angina | Q73294339 | ||
| Basal and flow-mediated nitric oxide production by atheromatous coronary arteries | Q73310472 | ||
| Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase? | Q73381671 | ||
| Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women | Q73453158 | ||
| Inhibition of nitric oxide synthesis during the cold pressor test in patients with coronary artery disease | Q73456992 | ||
| P433 | issue | 2 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 255-267 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases | |
| P478 | volume | 154 |
| Q37969832 | A review of the evidence for the effects of total dietary fat, saturated, monounsaturated and n-6 polyunsaturated fatty acids on vascular function, endothelial progenitor cells and microparticles |
| Q28196926 | Anti-thrombotic activity of PDR, a newly synthesized L-Arg derivative, on three thrombosis models in rats |
| Q43016383 | Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy |
| Q35058219 | Efficacy of over-the-counter nutritional supplements |
| Q35050418 | Emerging therapeutic targets in nitric oxide-dependent cardiac disease |
| Q92479661 | Endothelial, Cardiovascular, and Performance Responses to L-Arginine Intake and Resistance Exercise |
| Q35093076 | Endothelium and the lipid metabolism: the current understanding. |
| Q44683780 | Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium |
| Q37851964 | L-Arginine as a potential ergogenic aid in healthy subjects |
| Q41767433 | L-arginine and Alzheimer's disease. |
| Q35055189 | L-arginine in cardiovascular disease: dream or reality? |
| Q44623142 | L-arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats |
| Q34515458 | Pharmacological approaches to preserving and restoring coronary endothelial function |
| Q46813270 | Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study |
| Q40017806 | Smoking increases salivary arginase activity in patients with dental implants |
| Q34595721 | Vascular effects of dietary L-arginine supplementation |
Search more.